Journal of Cellular & Molecular Anesthesia
Outlines
The Potential Use of “Magnoliae flos” Against COVID-19
Author(s):
1Hong PTL, Kim HJ, Kim WK, Nam JH. Flos magnoliae constituent fargesin has an anti-allergic effect via ORAI1 channel inhibition. Korean J Physiol Pharmacol. 2021;25(3):251-8
Published online:Feb 16, 2022
Article type:Letter
How to Cite:Siukan LawThe Potential Use of “Magnoliae flos” Against COVID-19.J Cell Mol Anesth.7(1):e151414.https://doi.org/10.22037/jcma.v7i1.37634.
Abstract
References
- 1.References are in the PDF file of the article.
Copyright
© 2022, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
comments
Leave a comment here
Crossmark
Checking
Comments
Number of Comments:0Cited by
Purchasing Reprints
- Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations
Related Articles